LRCX vs TLRY · P/E 71, rev $23.23B vs rev $915.5M
Lam Research Corp (LRCX) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
Lam Research Corp (LRCX) is a semiconductor equipment & materials company listed on NASDAQ. It is led by Timothy M. Archer.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported LRCX revenue for 2026-06-28 was $23.23B. Net income was $7.27B. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
LRCX currently screens at market cap $467.94B and trailing P/E 70.9. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the LRCX and TLRY stock pages for the full models.
Not investment advice.